Key clinical highlights in HIV infection and COVID-19 are discussed in this interview with touchINFECTIOUS DISEASES Editorial Board member, Dr Nikolaus Jilg (Infectious Diseases Physician, Massachusetts General Hospital, Boston, MA, USA). Dr Jilg discusses the COVID-19 pandemic, the successful rollout of vaccines, the development of new treatments for COVID-19 and long-COVID, and markers of protection in future infections. He also discusses the progress in the development of HIV treatments in the past year, with the use of injectable HIV antiretrovirals coming to market, and further developments in HIV cure.
Questions:
- What are the key clinical highlights from the past year in the field of infectious diseases? (0:16)
- What are the hot topics and latest research you are looking forward to exploring in 2022? (3:07)
Disclosures: Nikolaus Jilg receives salary support to his institution, Massachusetts General Hospital, by the AIDS Clinical Trials Group (ACTG) and Sagent Pharmaceuticals.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.
